News

Using Gibson SOLA at scale is intended to contribute to an agile and efficient approach to biologics discovery. The Gibson SOLA platform has been shown to enable fully-enzymatic, overnight, on-site ...
The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.
Telesis Bio Inc. , a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, today announced a new license ...
Chemists at UCL and the MRC Laboratory of Molecular Biology have demonstrated how RNA (ribonucleic acid) might have ...
A large-scale study (exRNAQC) outlines how blood tube type, RNA purification method, and processing time influence exRNA profiles. Results support new guidelines for researchers and diagnostic product ...
New research reveals that sunburn may be caused by RNA damage, not DNA, challenging long-held beliefs about UV exposure ...
Former President Joe Biden was recently diagnosed with prostate cancer. His staff said it is an aggressive cancer that has ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...
The expression of symptoms of viral infections is a byproduct of complex virus-host molecular pathways. These remain largely ...
Effective LNPs could be crucial for new mRNA vaccines, mRNA therapies, DNA gene therapies, and even CRISPR gene-editing thrapies. “Everyone is trying to figure out the next big ionizable lipid ...
From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...